In April 2023, the European Commission adopted a proposal for a new Directive and a new Regulation, aimed at revising and replacing the existing General Pharmaceutical Legislation (GPL). The proposal focuses on modernising the pharmaceutical sector with a patient-centred approach, while also fully supporting an innovative and competitive industry.

One of the sectors impacted by the proposal is that of biotechnology, which has been instrumental in the discovery and development of therapies, diagnostics, vaccines and, most importantly, advanced medicines.

Join this Euractiv Hybrid Conference to discuss Europe’s biotech innovation in light of the EU’s reform of the General Pharmaceutical Legislation.

 January 24, 2024  ·  Brussels, Belgium

12:30 PM - 1:45 PM (CET)